BNP PARIBAS ARBITRAGE/CALL/PFIZER INC/28/0.1/21.06.24 Stock

Warrant

W21NB

NLBNPFR1Y8V2

Market Closed - Euronext Paris 12:30:02 2024-06-04 EDT
0.155 EUR +14.81% Intraday chart for BNP PARIBAS ARBITRAGE/CALL/PFIZER INC/28/0.1/21.06.24
Current month+63.16%
1 month+106.67%
Date Price Change
24-06-04 0.155 +14.81%
24-06-03 0.135 +42.11%
24-05-31 0.095 +46.15%
24-05-30 0.065 0.00%
24-05-29 0.065 -23.53%

Real-time Euronext Paris

Last update June 04, 2024 at 12:30 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
W21NB
ISINNLBNPFR1Y8V2
Date issued 2024-02-07
Strike 28 $
Maturity 2024-06-21 (17 Days)
Parity 10 : 1
Emission price 0.1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.215
Lowest since issue 0.025
Spread 0.03
Spread %27.27%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
29.49 USD
Average target price
31.92 USD
Spread / Average Target
+8.22%
Consensus
  1. Stock Market
  2. Warrants
  3. W21NB Warrant